Korean Drug Co., Ltd. (KOSDAQ: 014570)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,840.00
-20.00 (-0.41%)
Dec 19, 2024, 9:00 AM KST
-31.15%
Market Cap 51.61B
Revenue (ttm) 74.41B
Net Income (ttm) -389.58M
Shares Out 10.91M
EPS (ttm) -36.26
PE Ratio n/a
Forward PE n/a
Dividend 150.00 (3.17%)
Ex-Dividend Date Dec 27, 2024
Volume 30,499
Open 4,860.00
Previous Close 4,860.00
Day's Range 4,515.00 - 4,860.00
52-Week Range 4,095.00 - 7,980.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 27, 2024

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 270
Stock Exchange KOSDAQ
Ticker Symbol 014570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.